Aytu Biopharma (AYTU) Depreciation and Depletion (2010 - 2026)

Aytu Biopharma (AYTU) reported Depreciation and Depletion of $100000.0 for Q1 2026, little changed year-over-year from $100000.0 in Q1 2025, and little changed quarter-over-quarter from $100000.0 in Q4 2025.

Aytu Biopharma (AYTU) Depreciation and Depletion (2010 - 2026) Analysis & Trends

Aytu Biopharma (AYTU) has 15 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q1 2026.

  • Depreciation and Depletion for Q1 2026 came in at $100000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $300000.0 (down 25.0% YoY), and the FY2025 annual result was $200000.0, down 77.78% from the prior year.
  • Depreciation and Depletion held at $100000.0 in Q1 2026 per AYTU's latest filing, from $100000.0 in the prior quarter.
  • Over five years, Depreciation and Depletion peaked at $500000.0 in Q1 2022 and troughed at $100000.0 in Q2 2024.
  • A 5-year average of $225000.0 and a median of $250000.0 in 2022 frame the typical range for Depreciation and Depletion.
  • The sharpest annual moves came in 2022 and 2024: Depreciation and Depletion changed 0.0% in 2022, then sank 66.67% in 2024.
  • A 5-year view of Depreciation and Depletion shows it stood at $400000.0 in 2022, then fell by 25.0% to $300000.0 in 2023, then sank by 66.67% to $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
  • Business Quant data shows AYTU's Depreciation and Depletion at $100000.0 in Q1 2026, $100000.0 in Q4 2025, and $100000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 36.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 21.60 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 7.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 28.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 Aytu Biopharma 24.60 Mn -2.12 Mn 7.60 Mn 100,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 100,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Sep 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 100,000.00
Dec 31, 2024 100,000.00
Sep 30, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Mar 31, 2024 200,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 300,000.00
Dec 31, 2023 300,000.00
Sep 30, 2023 300,000.00
Sep 30, 2023 300,000.00